FEATURED COMPANIES
- 20/20 GeneSystems Inc
- Biotechnologies Corp
- Diagnostics
- Diagnostics LLC
- Genomics Inc (Inactive)
- Medicine Inc
Summary
The publisher's Medical Devices sector report, “Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Therapeutic Drug Monitoring Tests reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat. Test kits for measurement of both proteins based and chemical based therapeutic drugs are covered.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
The report enables you to -
The publisher's Medical Devices sector report, “Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Therapeutic Drug Monitoring Tests reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat. Test kits for measurement of both proteins based and chemical based therapeutic drugs are covered.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Therapeutic Drug Monitoring Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Therapeutic Drug Monitoring Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Therapeutic Drug Monitoring Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- 20/20 GeneSystems Inc
- Biotechnologies Corp
- Diagnostics
- Diagnostics LLC
- Genomics Inc (Inactive)
- Medicine Inc
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Therapeutic Drug Monitoring Tests Overview
3 Products under Development
3.1 Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
3.2 Therapeutic Drug Monitoring - Pipeline Products by Segment
3.3 Therapeutic Drug Monitoring - Pipeline Products by Territory
3.4 Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
3.5 Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
3.6 Therapeutic Drug Monitoring - Ongoing Clinical Trials
4 Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
4.1 Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
4.2 Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
5 Therapeutic Drug Monitoring Companies and Product Overview
6 Therapeutic Drug Monitoring- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 2: Therapeutic Drug Monitoring - Pipeline Products by Segment
Table 3: Therapeutic Drug Monitoring - Pipeline Products by Territory
Table 4: Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table 5: Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table 6: Therapeutic Drug Monitoring - Ongoing Clinical Trials
Table 7: Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table 8: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 9: 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PredicTOR Breast Test - Product Status
Table 11: PredicTOR Breast Test - Product Description
Table 12: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Alinity c Assay - Digitoxin - Product Status
Table 14: Alinity c Assay - Digitoxin - Product Description
Table 15: Alinity ci Assay - TDM - Product Status
Table 16: Alinity ci Assay - TDM - Product Description
Table 17: ARCHITECT c4000 - Methotrexate Assay - Product Status
Table 18: ARCHITECT c4000 - Methotrexate Assay - Product Description
Table 19: ARCHITECT c8000 Integrated System - Methotrexate Assay - Product Status
Table 20: ARCHITECT c8000 Integrated System - Methotrexate Assay - Product Description
Table 21: ARCHITECT i2000SR System - Methotrexate Assay - Product Status
Table 22: ARCHITECT i2000SR System - Methotrexate Assay - Product Description
Table 23: Accelerated Medical Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 24: PlatinDx Assay - Bladder Cancer - Product Status
Table 25: PlatinDx Assay - Bladder Cancer - Product Description
Table 26: PlatinDx Assay - Lung Cancer - Product Status
Table 27: PlatinDx Assay - Lung Cancer - Product Description
Table 28: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Immune System Profiling - Measure Of Vaccine Efficacy - Product Status
Table 30: Immune System Profiling - Measure Of Vaccine Efficacy - Product Description
Table 31: Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Phage-Based Assay - Product Status
Table 33: Phage-Based Assay - Product Description
Table 34: Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: ONCO4D Assay - Product Status
Table 36: ONCO4D Assay - Product Description
Table 37: Animated Dynamics Inc - Ongoing Clinical Trials Overview
Table 38: ONCO4D Assay - Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response
Table 39: Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview
Table 40: SNP-test - Product Status
Table 41: SNP-test - Product Description
Table 42: ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: ARK Apixaban Assay - Product Status
Table 44: ARK Apixaban Assay - Product Description
Table 45: ARK Atazanavir Assay - Product Status
Table 46: ARK Atazanavir Assay - Product Description
Table 47: ARK Dabigatran Assay - Product Status
Table 48: ARK Dabigatran Assay - Product Description
Table 49: ARK Darunavir Assay - Product Status
Table 50: ARK Darunavir Assay - Product Description
Table 51: ARK Dolutegravir Assay - Product Status
List of Figures
Figure 1: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Figure 2: Therapeutic Drug Monitoring - Pipeline Products by Segment
Figure 3: Therapeutic Drug Monitoring - Pipeline Products by Territory
Figure 4: Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Figure 5: Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Figure 6: Therapeutic Drug Monitoring - Ongoing Clinical Trials
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Therapeutic Drug Monitoring Tests Overview
3 Products under Development
3.1 Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
3.2 Therapeutic Drug Monitoring - Pipeline Products by Segment
3.3 Therapeutic Drug Monitoring - Pipeline Products by Territory
3.4 Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
3.5 Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
3.6 Therapeutic Drug Monitoring - Ongoing Clinical Trials
4 Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
4.1 Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
4.2 Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
5 Therapeutic Drug Monitoring Companies and Product Overview
6 Therapeutic Drug Monitoring- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 2: Therapeutic Drug Monitoring - Pipeline Products by Segment
Table 3: Therapeutic Drug Monitoring - Pipeline Products by Territory
Table 4: Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table 5: Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table 6: Therapeutic Drug Monitoring - Ongoing Clinical Trials
Table 7: Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table 8: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 9: 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PredicTOR Breast Test - Product Status
Table 11: PredicTOR Breast Test - Product Description
Table 12: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Alinity c Assay - Digitoxin - Product Status
Table 14: Alinity c Assay - Digitoxin - Product Description
Table 15: Alinity ci Assay - TDM - Product Status
Table 16: Alinity ci Assay - TDM - Product Description
Table 17: ARCHITECT c4000 - Methotrexate Assay - Product Status
Table 18: ARCHITECT c4000 - Methotrexate Assay - Product Description
Table 19: ARCHITECT c8000 Integrated System - Methotrexate Assay - Product Status
Table 20: ARCHITECT c8000 Integrated System - Methotrexate Assay - Product Description
Table 21: ARCHITECT i2000SR System - Methotrexate Assay - Product Status
Table 22: ARCHITECT i2000SR System - Methotrexate Assay - Product Description
Table 23: Accelerated Medical Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 24: PlatinDx Assay - Bladder Cancer - Product Status
Table 25: PlatinDx Assay - Bladder Cancer - Product Description
Table 26: PlatinDx Assay - Lung Cancer - Product Status
Table 27: PlatinDx Assay - Lung Cancer - Product Description
Table 28: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Immune System Profiling - Measure Of Vaccine Efficacy - Product Status
Table 30: Immune System Profiling - Measure Of Vaccine Efficacy - Product Description
Table 31: Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Phage-Based Assay - Product Status
Table 33: Phage-Based Assay - Product Description
Table 34: Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: ONCO4D Assay - Product Status
Table 36: ONCO4D Assay - Product Description
Table 37: Animated Dynamics Inc - Ongoing Clinical Trials Overview
Table 38: ONCO4D Assay - Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response
Table 39: Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview
Table 40: SNP-test - Product Status
Table 41: SNP-test - Product Description
Table 42: ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: ARK Apixaban Assay - Product Status
Table 44: ARK Apixaban Assay - Product Description
Table 45: ARK Atazanavir Assay - Product Status
Table 46: ARK Atazanavir Assay - Product Description
Table 47: ARK Dabigatran Assay - Product Status
Table 48: ARK Dabigatran Assay - Product Description
Table 49: ARK Darunavir Assay - Product Status
Table 50: ARK Darunavir Assay - Product Description
Table 51: ARK Dolutegravir Assay - Product Status
List of Figures
Figure 1: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Figure 2: Therapeutic Drug Monitoring - Pipeline Products by Segment
Figure 3: Therapeutic Drug Monitoring - Pipeline Products by Territory
Figure 4: Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Figure 5: Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Figure 6: Therapeutic Drug Monitoring - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
- 20/20 GeneSystems Inc
- Diagnostics
- Medical Diagnostics LLC
- Biotechnologies Corp
- Dynamics Inc
- Research using OMIC Sciences SL
- Diagnostics Inc
- Group Plc
- Medicine Inc
- Scientific SL
- Diagnostics Inc
- Children's Hospital
- Genetics Inc
- Diagnostics LLC
- Hospitalier Universitaire de Nice
- Biomedical Inc
- Biomarkers LLC
- Superior de Investigaciones Cientificas
- Genomics Inc (Inactive)
- City University Inc
- Scientific SA
- Hutchinson Cancer Research Center
Note: Product cover images may vary from those shown
